Becton, Dickinson and Co. (BDX) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention produc...
Becton, Dickinson and Co. (BDX) currently trades at a P/E ratio of 33.63 (historical range: 32.19–58.82, median: 40.31), placing it at the 5th percentile — cheap relative to its history, P/S ratio of 2.70 (range: 2.39–4.19, 24th percentile — below its historical average), EV/EBITDA of 141.09 (range: 30.14–206.40, 70th percentile).
Becton, Dickinson and Co. appears undervalued relative to its historical range, with most valuation metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 33.63 | 32.19 | 40.31 | 58.82 | 5th | cheap relative to its history |
| P/S Ratio | 2.70 | 2.39 | 3.07 | 4.19 | 24th | below its historical average |
| EV/EBITDA | 141.09 | 30.14 | 50.85 | 206.40 | 70th | above its historical average |
| FCF Yield | 0.01 | 0.01 | 0.03 | 0.05 | 31th | above its historical average |